Becker Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Becker Muscular Dystrophy Pipeline Drugs Market Report Overview
Becker muscular dystrophy pipeline market research report provides comprehensive information on the therapeutics under development for Becker Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Becker Muscular Dystrophy and features dormant and discontinued projects.
Key Targets in the Becker Muscular Dystrophy Pipeline Market
The key targets in the Becker Muscular Dystrophy pipeline market are Androgen Receptor, Cardiolipin, Follistatin, Glucagon Like Peptide 1 Receptor, Glucocorticoid Receptor, Growth/Differentiation Factor 8, Histone Deacetylase 1, Histone Deacetylase 2, Myosin ATPase, and Ryanodine Receptor.
Key MoA in the Becker Muscular Dystrophy Pipeline Market
The key MoA in the Becker Muscular Dystrophy pipeline market are Androgen Receptor Agonist, Follistatin Activator, Glucagon Like Peptide 1 Receptor Agonist, Glucocorticoid Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Histone Deacetylase 1 Inhibitor, and Histone Deacetylase 2 Inhibitor.
Key RoA in the Becker Muscular Dystrophy Pipeline Market
The key RoA in the Becker Muscular Dystrophy pipeline market are oral, intravenous, subcutaneous, intramuscular, and ophthalmic. Oral has the highest number of pipeline products.
Becker Muscular Dystrophy Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Becker Muscular Dystrophy Pipeline Market
The key molecule types in the Becker Muscular Dystrophy pipeline market are small molecule, fusion protein, gene therapy, monoclonal antibody, recombinant protein, and synthetic peptide. Small molecule has the highest number of pipeline products.
Becker Muscular Dystrophy Pipeline Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Becker Muscular Dystrophy Pipeline Market
The key companies in the Becker Muscular Dystrophy pipeline market are Epirium Bio Inc, ARMGO Pharma Inc, Edgewise Therapeutics Inc, Italfarmaco SpA, Milo Biotechnology LLC, PhaseBio Pharmaceuticals Inc, Santhera Pharmaceuticals Holding AG, and Sarcomed AB. Epirium Bio Inc has the highest number of pipeline products.
Becker Muscular Dystrophy Pipeline Market, by Companies
To know more about companies, download a free report sample
Market report overview
Key targets | Androgen Receptor, Cardiolipin, Follistatin, Glucagon Like Peptide 1 Receptor, Glucocorticoid Receptor, Growth/Differentiation Factor 8, Histone Deacetylase 1, Histone Deacetylase 2, Myosin ATPase, and Ryanodine Receptor |
Key MoA | Androgen Receptor Agonist, Follistatin Activator, Glucagon Like Peptide 1 Receptor Agonist, Glucocorticoid Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Histone Deacetylase 1 Inhibitor, and Histone Deacetylase 2 Inhibitor |
Key RoA | Oral, Intravenous, Subcutaneous, Intramuscular, and Ophthalmic |
Key molecule types | Small Molecule, Fusion Protein, Gene Therapy, Monoclonal Antibody, Recombinant Protein, and Synthetic Peptide |
Key companies | Epirium Bio Inc, ARMGO Pharma Inc, Edgewise Therapeutics Inc, Italfarmaco SpA, Milo Biotechnology LLC, PhaseBio Pharmaceuticals Inc, Santhera Pharmaceuticals Holding AG, and Sarcomed AB |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Becker Muscular Dystrophy (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Becker Muscular Dystrophy (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Becker Muscular Dystrophy (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Becker Muscular Dystrophy (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Becker Muscular Dystrophy (Genetic Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Becker Muscular Dystrophy (Genetic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Becker Muscular Dystrophy (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Edgewise Therapeutics Inc
Epirium Bio Inc
Italfarmaco SpA
Milo Biotechnology LLC
PhaseBio Pharmaceuticals Inc
Santhera Pharmaceuticals Holding AG
Sarcomed AB
Scholar Rock Inc
Stealth BioTherapeutics Corp
Tivorsan Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Becker Muscular Dystrophy pipeline market?
The key targets in the Becker Muscular Dystrophy pipeline market are Androgen Receptor, Cardiolipin, Follistatin, Glucagon Like Peptide 1 Receptor, Glucocorticoid Receptor, Growth/Differentiation Factor 8, Histone Deacetylase 1, Histone Deacetylase 2, Myosin ATPase, and Ryanodine Receptor.
-
What are the key MoA in the Becker Muscular Dystrophy pipeline market?
The key MoA in the Becker Muscular Dystrophy pipeline market are Androgen Receptor Agonist, Follistatin Activator, Glucagon Like Peptide 1 Receptor Agonist, Glucocorticoid Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Histone Deacetylase 1 Inhibitor, and Histone Deacetylase 2 Inhibitor.
-
What are the key RoA in the Becker Muscular Dystrophy pipeline market?
The key RoA in the Becker Muscular Dystrophy pipeline market are oral, intravenous, subcutaneous, intramuscular, and ophthalmic.
-
What are the key molecule types in the Becker Muscular Dystrophy pipeline market?
The key molecule types in the Becker Muscular Dystrophy pipeline market are small molecule, fusion protein, gene therapy, monoclonal antibody, recombinant protein, and synthetic peptide.
-
What are the key companies in the Becker Muscular Dystrophy pipeline market?
The key companies in the Becker Muscular Dystrophy pipeline market are Epirium Bio Inc, ARMGO Pharma Inc, Edgewise Therapeutics Inc, Italfarmaco SpA, Milo Biotechnology LLC, PhaseBio Pharmaceuticals Inc, Santhera Pharmaceuticals Holding AG, and Sarcomed AB.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.